Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Integrated Artificial Intelligence Approach for Predicting Analgesic Time Based on Nalbuphine Versus Morphine as Adjuvants to Bupivacaine in Ultrasound-Guided Supraclavicular Block

NCT07008443 is registered in ClinicalTrials.gov with Alzahraa Ahmed Abbas as lead sponsor.

NCT NCT07008443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07008443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Integrated Artificial Intelligence Approach for Predicting Analgesic Time Based on Nalbuphine Versus Morphine as Adjuvants to Bupivacaine in Ultrasound-Guided Supraclavicular Block
Lead sponsor
Alzahraa Ahmed Abbas
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2024
Completion date
April 1, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

regional anesthesia block, upper limb surgery